元鉴
返回中文阅读流
Nature Medicine2026-07-24

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

Nature Medicine, Published online: 24 July 2026; doi:10.1038/s41591-026-04496-2 In the LITMUS study, serum biomarkers outperformed imaging for identifying patients at risk of MASH, whereas elastography was superior for staging advanced fibrosis and cirrhosis.

待翻译research literature英文原文正文翻译排队
正文翻译排队

该来源正文已进入翻译队列，中文正文生成前先展示摘要和原始出处入口。

摘要

Nature Medicine, Published online: 24 July 2026; doi:10.1038/s41591-026-04496-2 In the LITMUS study, serum biomarkers outperformed imaging for identifying patients at risk of MASH, whereas elastography was superior for staging advanced fibrosis and cirrhosis.

Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study

Nature Medicine, Published online: 24 July 2026; doi:10.1038/s41591-026-04496-2 In the LITMUS study, serum biomarkers outperformed imaging for identifying patients at risk of MASH, whereas elastography was superior for staging advanced fibrosis and cirrhosis.